blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1783226

EP1783226 - AAV structural protein, production and use thereof [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.07.2009
Database last updated on 17.07.2024
Most recent event   Tooltip24.07.2009Application deemed to be withdrawnpublished on 26.08.2009  [2009/35]
Applicant(s)For all designated states
MediGene AG
Lochhamer Strasse 11
82152 Planegg/Martinsried / DE
[2007/19]
Inventor(s)01 / Hallek, Michael
Max-Scheler-Strasse 11
50935 Köln / DE
02 / Ried, Martin
Waldstrasse 3c
82319 Starnberg / DE
03 / Deleage, Gilbert
43, rue Saint Romain
69008 Lyon / FR
04 / Girod, Anne
Birkenstrasse 7
82287 Jesenwang / DE
 [2007/19]
Representative(s)Bösl, Raphael Konrad
Patentanwälte Isenbruck Bösl Hörschler PartG mbB
Eastsite One
Seckenheimer Landstraße 4
68163 Mannheim / DE
[N/P]
Former [2007/19]Bösl, Raphael Konrad
Patentanwälte Isenbruck Bösl Hörschler Wichmann Huhn Prinzregentenstrasse 68
81675 München / DE
Application number, filing date06018533.721.06.1999
[2007/19]
Priority number, dateDE1998102745719.06.1998         Original published format: DE 19827457
[2007/19]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP1783226
Date:09.05.2007
Language:DE
[2007/19]
Search report(s)(Supplementary) European search report - dispatched on:EP12.04.2007
ClassificationIPC:C12N15/35, C12N15/62, C07K14/015, C12N5/10, A61K39/23, A61K48/00, G01N33/68, C12Q1/68
[2007/19]
CPC:
C07K14/005 (EP,US); A61P31/12 (EP); A61K38/00 (EP,US);
A61K48/00 (EP,US); C12N2750/14122 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2007/19]
TitleGerman:Strukturprotein von AAV, seine Herstellung und Verwendung[2007/19]
English:AAV structural protein, production and use thereof[2007/19]
French:Protéine structurale de Virus Associé aux Adenovirus, sa production et son utilisation[2007/19]
Examination procedure05.09.2006Examination requested  [2007/19]
12.02.2008Despatch of a communication from the examining division (Time limit: M04)
13.06.2008Reply to a communication from the examining division
22.08.2008Despatch of a communication from the examining division (Time limit: M06)
03.03.2009Application deemed to be withdrawn, date of legal effect  [2009/35]
07.04.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2009/35]
Parent application(s)   TooltipEP99929292.3  / EP1088075
Fees paidRenewal fee
05.09.2006Renewal fee patent year 03
05.09.2006Renewal fee patent year 04
05.09.2006Renewal fee patent year 05
05.09.2006Renewal fee patent year 06
05.09.2006Renewal fee patent year 07
05.09.2006Renewal fee patent year 08
28.06.2007Renewal fee patent year 09
26.03.2008Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[AD]WO9600587  (UNIV PITTSBURGH [US]) [AD] 1-24 * page 5, line 10 - line 14 * * page 23, line 11 - page 24, line 25 *;
 [X]WO9738723  (IMMUSOL INC [US], et al) [X] 1-11,15,18-24 * page 4, line 21 - page 5, line 2 * * page 17, line 11 - page 18, line 2 * * page 26, line 17 - page 27, line 7 * * example 1 * * example 2C *;
 [E]WO9967393  (MEDIGENE AG [DE], et al) [E] 1-24* the whole document *;
 [AD]  - OHNO K. ET AL., "Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A.", NATURE BIOTECHNOLOGY, (199708), vol. 15, pages 763 - 767, XP002128038 [AD] 1-24 * column W *

DOI:   http://dx.doi.org/10.1038/nbt0897-763
 [AD]  - WICKHAM T. J. ET AL., "Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types.", NATURE BIOTECHNOLOGY, (199611), vol. 14, pages 1570 - 1573, XP002128039 [AD] 1-24 * column W *

DOI:   http://dx.doi.org/10.1038/nbt1196-1570
 [PXD]  - YANG Q. ET AL., "Development of novel cell surface CD34-targeted recombinant adenoassociated virus vectors for gene therapy.", HUMAN GENE THERAPY, (199809), vol. 9, pages 1929 - 1937, XP000867311 [PXD] 1-11,15,18-24 * column W *
 [T]  - GIROD A. ET AL., "GENETIC CAPSID MODIFICATIONS ALLOW EFFICIENT RE-TARGETING OF ADENO-ASSOCIATED VIRUS TYPE 2", NATURE MEDICINE, (1999), vol. 5, no. 9, pages 1052 - 1056, XP002128040 [T] 1-24 * column W *

DOI:   http://dx.doi.org/10.1038/12491
by applicantWO9523867
 WO9600587
    - SRIVASTAVA, A., J. VIROL., (1983), vol. 45, pages 555 - 564
    - MUZYCZKA, N., CURR. TOP. MICRO. IMMUNOL., (1992), vol. 158, pages 97 - 129
    - RUFFING, N., J. VIROL., (1992), vol. 66, pages 6922 - 6930
    - RUTLEDGE, E. A., J. VIROL., (1998), vol. 72, pages 309 - 319
    - KOTIN, R. M., HUMAN GENE THERAPY, (1994), vol. 5, pages 793 - 801
    - CHIORINI, J. A., HUMAN GENE THERAPY, (1995), vol. 6, pages 1531 - 1541
    - MASS, HUMAN GENE THERAPY, (1998), vol. 9, pages 1049 - 1059
    - MIZUKAMI, H., VIROLOGY, (1996), vol. 217, pages 124 - 130
    - SUMMERFORD, C.; SAMULSKI, R. J., J. VIROL., (1998), vol. 72, pages 1438 - 1445
    - SUMMERFORD, NATURE MEDICINE, (1999), vol. 5, pages 78 - 82
    - QING, NATURE MEDICINE, (1999), vol. 5, pages 71 - 77
    - COSSET, F. L.; RUSSE LL, S. J., GENE THER., (1996), vol. 3, pages 946 - 956
    - DOUGLAS, J. T., NAT. BIOTECHNOL., (1996), vol. 14, pages 1574 - 1578
    - KRASNYKH, V. N., J. VIROL., (1996), vol. 70, pages 6839 - 6846
    - STEVENSON, S. C., J. VIROL., (1997), vol. 71, pages 4782 - 4790
    - WICKHAM, T. J., NAT. BIOTECHNOL., (1996), vol. 14, pages 1570 - 1573
    - RUFFING, J. GEN.VIROL., (1994), vol. 75, pages 3385 - 3392
    - BARTLETT, NAT. BIOTECHNOL., (1999), vol. 17, pages 181 - 186
    - YANG, HUM. GENE THER., (1998), vol. 1, pages 1929 - 1937
    - LUO M., J. MOL. BIOL., (1988), vol. 200, pages 209 - 211
    - WU; ROSSMANN, J.MOL.BIOL., (1993), vol. 233, pages 231 - 244
    - STAROVASNIK, PROC.NATL.ACAD.SCI. USA, (1997), vol. 16, no. 94, pages 10080 - 10085
    - OHNO, NAT. BIOTECH., (1997), vol. 15, pages 763 - 767
    - HERMONAT, P. L., J. VIROL., (1984), vol. 51, pages 329 - 339
    - VALSESIA-WITTMANN, S., J. VIROL., (1994), vol. 68, pages 4609 - 4619
    - HERMONAT, JOURNAL OF VIROLOGY, (1984), vol. 51, pages 329 - 339
    - AUMAILLY, FEBS LETT., (1990), vol. 262, pages 82 - 86
    - WISTUBA, J. VIROL., (1997), vol. 71, pages 1341 - 1352
    - VALSESIA-WITTMANN, J. VIROL., (1994), vol. 68, pages 4609 - 4619
    - MAASS, G., HUM. GEN. THER., (1998), vol. 9, pages 1049 - 1059
    - WISTUBA, J. VIROL., (1995), vol. 69, pages 5311 - 5319
    - CHIORINI, HUM. GEN. THER., (1995), vol. 6, pages 1531 - 1541
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.